
KENNA ZHANG
Kenna, the CEO of CognifyAI, utilizes her knowledge of training artificial intelligence to create and test machine learning algorithms that recognize signs of Parkinson’s Disease.
CognifyAI aims to revolutionize early detection of Parkinson's disease through its innovative approach and accessible software.
At CognifyAI, we are committed to transforming the landscape of neurological health through innovative technology that leverages voice analysis and hand-drawing assessments to facilitate the early detection of Parkinson’s disease. Our mission is to create a world where advanced diagnostic tools are not limited by geographic, financial, or technological barriers. By integrating sophisticated machine learning algorithms with an intuitive user experience, we empower individuals and healthcare providers alike to uncover subtle, early-stage indicators of neurodegenerative conditions with precision and ease. Through this commitment, we seek to improve lives, enhance outcomes, and contribute meaningfully to a future defined by equitable access to groundbreaking medical innovations.
CognifyAI is innovated by a team of two teenage girls from North Carolina who strive for collaboration, excellence, communication, and equity. Behind each of these girls is a grandparent who struggles with a neuro-degenerative disease. The hesitance of their grandparents to seek medical help inspired them to make a change that would enhance early diagnosis for one of these diseases, Parkinson's disease.

Kenna, the CEO of CognifyAI, utilizes her knowledge of training artificial intelligence to create and test machine learning algorithms that recognize signs of Parkinson’s Disease.

Claire, the CTO of CognifyAI, employs her interest in computer science and web development to maintain accessible and user-friendly software that is simple and straightforward to use.